Cambridge Investment Research Advisors’s Brookfield BN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.1M | Buy |
259,625
+13,816
| +6% | +$618K | 0.02% | 627 |
|
|
2026
Q1 | $9.94M | Buy |
245,809
+33,188
| +16% | +$1.47M | 0.03% | 622 |
|
|
2025
Q4 | $9.77M | Buy |
212,621
+18,828
| +10% | +$859K | 0.03% | 592 |
|
|
2025
Q3 | $8.87M | Sell |
193,793
-13,042
| -6% | -$578K | 0.02% | 623 |
|
|
2025
Q2 | $8.52M | Sell |
206,835
-6,047
| -3% | -$224K | 0.03% | 603 |
|
|
2025
Q1 | $7.43M | Buy |
212,882
+4,370
| +2% | +$165K | 0.03% | 616 |
|
|
2024
Q4 | $7.99M | Sell |
208,512
-440
| -0.2% | -$16.6K | 0.03% | 577 |
|
|
2024
Q3 | $7.41M | Buy |
208,952
+18,444
| +10% | +$582K | 0.03% | 614 |
|
|
2024
Q2 | $5.28M | Buy |
190,508
+6,771
| +4% | +$189K | 0.02% | 728 |
|
|
2024
Q1 | $5.13M | Buy |
183,737
+5,123
| +3% | +$138K | 0.02% | 727 |
|
|
2023
Q4 | $4.78M | Buy |
178,614
+9,420
| +6% | +$214K | 0.02% | 727 |
|
|
2023
Q3 | $3.53M | Buy |
169,194
+21,721
| +15% | +$489K | 0.02% | 838 |
|
|
2023
Q2 | $3.31M | Buy |
147,473
+4,574
| +3% | +$96.9K | 0.02% | 873 |
|
|
2023
Q1 | $3.1M | Buy |
142,899
+15,333
| +12% | +$345K | 0.02% | 884 |
|
|
2022
Q4 | $2.67M | Sell |
127,566
-19,417
| -13% | -$435K | 0.01% | 920 |
|
|
2022
Q3 | $3.24M | Buy |
146,983
+14,795
| +11% | +$383K | 0.02% | 779 |
|
|
2022
Q2 | $3.17M | Sell |
132,188
-9,223
| -7% | -$246K | 0.02% | 816 |
|
|
2022
Q1 | $4.31M | Sell |
141,411
-20,147
| -12% | -$602K | 0.02% | 702 |
|
|
2021
Q4 | $5.26M | Buy |
161,558
+17,900
| +12% | +$566K | 0.02% | 621 |
|
|
2021
Q3 | $4.14M | Buy |
143,658
+4,347
| +3% | +$127K | 0.02% | 692 |
|
|
2021
Q2 | $3.83M | Buy |
139,311
+3,322
| +2% | +$85.1K | 0.02% | 752 |
|
|
2021
Q1 | $3.24M | Buy |
135,989
+35,190
| +35% | +$785K | 0.02% | 764 |
|
|
2020
Q4 | $2.23M | Buy |
100,799
+1,920
| +2% | +$38.4K | 0.01% | 874 |
|
|
2020
Q3 | $1.75M | Buy |
98,879
+9,980
| +11% | +$178K | 0.01% | 871 |
|
|
2020
Q2 | $1.56M | Buy |
88,899
+25,577
| +40% | +$450K | 0.01% | 885 |
|
|
2020
Q1 | $1M | Sell |
63,322
-104,455
| -62% | -$2.15M | 0.01% | 970 |
|
|
2019
Q4 | $3.46M | Buy |
167,777
+40,127
| +31% | +$800K | 0.03% | 596 |
|
|
2019
Q3 | $2.42M | Buy |
127,650
+78,454
| +159% | +$1.42M | 0.02% | 672 |
|
|
2019
Q2 | $839K | Buy |
49,196
+10,757
| +28% | +$182K | 0.01% | 1122 |
|
|
2019
Q1 | $640K | Buy |
38,439
+4,240
| +12% | +$66K | 0.01% | 1319 |
|
|
2018
Q4 | $468K | Sell |
34,199
-6,516
| -16% | -$97.2K | 0.01% | 1361 |
|
|
2018
Q3 | $647K | Buy |
40,715
+168
| +0.4% | +$2.55K | 0.01% | 1295 |
|
|
2018
Q2 | $586K | Buy |
40,547
+6,480
| +19% | +$92.5K | 0.01% | 1317 |
|
|
2018
Q1 | $474K | Buy |
34,067
+1,219
| +4% | +$17.6K | 0.01% | 1381 |
|
|
2017
Q4 | $510K | Sell |
32,848
-4,325
| -12% | -$65.3K | 0.01% | 1312 |
|
|
2017
Q3 | $548K | Buy |
37,173
+2,038
| +6% | +$28.6K | 0.01% | 1212 |
|
|
2017
Q2 | $492K | Buy |
35,135
+1,502
| +4% | +$20.2K | 0.01% | 1213 |
|
|
2017
Q1 | $438K | Buy |
33,633
+1,261
| +4% | +$16K | 0.01% | 1141 |
|
|
2016
Q4 | $381K | Buy |
32,372
+1,895
| +6% | +$23.1K | 0.01% | 1143 |
|
|
2016
Q3 | $383K | Sell |
30,477
-5,367
| -15% | -$65.7K | 0.01% | 1171 |
|
|
2016
Q2 | $423K | Buy |
35,844
+5,116
| +17% | +$61.2K | 0.01% | 1012 |
|
|
2016
Q1 | $375K | Sell |
30,728
-19,062
| -38% | -$205K | 0.01% | 1053 |
|
|
2015
Q4 | $551K | Sell |
49,790
-1,612
| -3% | -$18.9K | 0.01% | 815 |
|
|
2015
Q3 | $568K | Buy |
51,402
+15,318
| +42% | +$179K | 0.02% | 698 |
|
|
2015
Q2 | $443K | Buy |
36,084
+8,914
| +33% | +$113K | 0.01% | 870 |
|
|
2015
Q1 | $341K | Buy |
+27,170
| New | +$337K | 0.01% | 994 |
|
Other funds holding BN
PVI
PSCM
BC
Cambridge Investment Research Advisors's BN Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its Brookfield (BN) stake by 5.6% in Q2 2026, buying an estimated $618K and bringing the position to 259,625 shares worth $11.1M. The position accounts for 0.02% of the portfolio, ranked #627.
Cambridge Investment Research Advisors first reported a position in BN in Q1 2015 and has held it in 46 quarters since. 940 funds tracked by Wall St. Rank hold BN as of Q2 2026.
- Cambridge Investment Research Advisors held 259,625 shares of Brookfield worth $11.1M as of Q2 2026.
- Cambridge Investment Research Advisors bought 13,816 Brookfield shares in Q2 2026, an estimated $618K.
- Brookfield made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #627 holding.
- Cambridge Investment Research Advisors first reported a position in Brookfield in Q1 2015 and has held it in 46 quarters since.
- 940 funds tracked by Wall St. Rank held Brookfield as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.